Persistent pulmonary hypertension of newborn due to congenital capillary alveolar dysplasia

Pediatric Pulmonology

Volumn 40, Issue 4, 2005, Pages 349-353

  Singh, Soraisham Amuchou ^a,c   Ibrahim, Thowfique ^a   Clark, Deborah Jane ^a   Taylor, Richard Scott ^a   George, David Hilles ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

Alveolar capillary dysplasia; Neonate; Persistent pulmonary hypertension

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; CEFOTAXIME; DILTIAZEM; DIPYRIDAMOLE; DOPAMINE; HEPARIN; INOTROPIC AGENT; LUNG SURFACTANT; MAGNESIUM SULFATE; MILRINONE; MORPHINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PANCURONIUM; PROSTACYCLIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2; TOLAZOLINE; VANCOMYCIN;

ARTICLE; AUTOPSY; CASE REPORT; CONGENITAL CAPILLARY ALVEOLAR DYSPLASIA; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOTENSION; LUNG BLOOD VESSEL; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN SEPSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THORAX RADIOGRAPHY; THROMBOEMBOLISM;

CAPILLARIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; LUNG; PULMONARY ALVEOLI;

EID: 26444545619     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20244     Document Type: Article

References (22)

1. Janney CG, Askin FB, Kuhn C. Congenital alveolar capillary dysplasia-an unusual cause of respiratory distress in the newborn. Am J Clin Pathol 1981;76:722-727.
2. Carter G, Thibeault DW, Beatty EC, Kilbride HW, Huntrakoon M. Misalignment of lung vessels and alveolar capillary dysplasia: a cause of persistent pulmonary hypertension. J Pediatr 1989;114: 293-300.
3. Cullinane C, Cox PN, Silver MM. Persistent pulmonary hypertension of the newborn due to alveolar capillary dysplasia. Pediatr Pathol 1992;12:499-514.
4. Chelliah BP, Brown D, Cohen M, Talleyrand AJ, Schwarz SS. Alveolar capillary dysplasia-a cause of persistent pulmonary hypertension unresponsive to a second course of extracorporeal membrane oxygenation. Pediatrics 1995;96:1159-1161.
5. Sirkin W, O'Hare BP, Cox PN, Perrin D, Cutz E, Silver MM. Alveolar capillary dysplasia: lung biopsy diagnosis, nitric oxide responsiveness, and bronchial generation count. Pediatr Pathol Lab Med 1997;17:125-132.
6. Steinhorn RH, Cox PN, Fineman JR, Finer NN, Rosenberg EM, Silver MM, Tyebkhan J, Zwass MS, Morin FC III. Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 1997;130:417-422.
7. Inwald D, Brown K, Gensini F, Malone M, Goldman A. Open lung biopsy in neonatal and paediatric patients referred for extracorporeal membrane oxygenation (ECMO). Thorax 2004;59: 328-333.
8. Al-Hathlol K, Phillips S, Seshia MK, Casiro O, Alvaro RE, Rigatto H. Alveolar capillary dysplasia. Report of a case of prolonged life without extracorporeal membrane oxygenation (ECMO) and review of the literature. Early Hum Dev 2000;57: 85-94.
9. Garola RE, Thibeault DW. Alveolar capillary dysplasia, with and without misalignment of pulmonary veins: an association of congenital anomalies. Am J Perinatol 1998;15:103-107.
10. Sen P, Thakur N, Stockton DW, Langston C, Bejjani BA. Expanding the phenotype of alveolar capillary dysplasia (ACD), J Pediatr 2004;145:646-651.
11. Abdallah HI, Karmazin N, Marks LA. Late presentation of misalignment of lung vessels with alveolar capillary dysplasia. Crit Care Med 1993;21:628-630.
12. Langston C. Misalignment of pulmonary veins and alveolar capillary dysplasia. Pediatr Pathol 1991;11:163-170.
13. Ng PC, Lewindon PJ, Siu YK, To KF, Wong W. Congenital misalignment of pulmonary vessels: an unusual syndrome associated with PPHN. Acta Paediatr 1995;84:349-353.
14. Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002; 141:830-832.
15. Kitayama Y, Kamata S, Okuyama H, Usui N, Sawai T, Kobayashi T, Fukui Y, Okada A. Nitric oxide inhalation therapy for an infant with persistent pulmonary hypertension caused by misalignment of pulmonary veins with alveolar capillary dysplasia. J Pediatr Surg 1997;32:99-100.
16. Licht C, Schickendantz S, Sreeram N, Arnold G, Rossi R, Vierzig A, Mennicken U, Roth B. Prolonged survival in alveolar capillary dysplasia syndrome. Eur J Pediatr 2004;163: 181-182.
17. Kinugasa H, Horigome H, Sugiura M, Saito T, Iijima T, Matsui A. Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia. Pediatr Int 2002;44:525-527.
18. Parker TA, Ivy DD, Kinsella JP, Torielli F, Ruyle SZ, Thilo EH, Abman SH. Combined therapy with inhaled nitric oxide and intravenous prostacycline in an infant with alveolar-capillary dysplasia. Am J Respir Crit Care Med 1997;155:743-746.
19. Stavert DM, Lehnert BE. Nitric oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief period. Inhal Toxicol 1990;2:53-67.
20. Montgomery V, Buchino JJ. Clinical pathologic conference: a newborn infant with pulmonary hypertension. J Pediatr 1998;133: 157-161.
21. Hunter WS, Becroft DMO. Congenital pulmonary lymphangiectasis associated with pleural effusions. Arch Dis Child 1984;59: 278-279.
22. Scott-Emuakpor AB, Warren ST, Kapur S, Quiachon EB, Higgins JV. Familial occurrence of congenital pulmonary lymphangiectasis. Am J Dis Child 1981;135:532-534.